| Business Summary | | Edwards
Lifesciences
Corp
provides
a
comprehensive
line
of
products
and
services
to
treat
late-stage
cardiovascular
disease.
The
Company's
sales
are
categorized
in
four
main
product
areas:
cardiac
surgery,
critical
care,
vascular,
and
perfusion
products
and
services.
Edwards
Lifesciences,
which
is
headquartered
in
Irvine,
California,
supplies
its
products
and
services
to
customers
in
more
than
80
countries,
both
through
direct
sales
and
distributor
relationships.
Edwards
Lifesciences'
products
are
manufactured
in
locations
throughout
the
world,
including
Brazil,
the
Dominican
Republic,
The
Netherlands,
Puerto
Rico,
Switzerland,
the
United
States
and,
through
a
contractual
joint
venture
with
Baxter
International,
Inc.,
Japan. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Edwards
Lifesciences
designs,
develops,
manufactures
and
markets
a
comprehensive
line
of
products
and
services
to
treat
late
stage
cardiovascular
disease.
For
the
six
months
ended
6/30/01,
revenues
decreased
11%
to
$384.3
million.
Net
loss
before
accounting
change
decreased
86%
to
$41.5
million.
Revenues
reflect
the
partial
divestiture
of
the
perfusion
products
line.
Earnings
also
reflect
a
decrease
in
disposition
of
assets
and
other
charges. | More
from
Market Guide: Significant
Developments |
| | | | FY2000
Compensation | | Pay | Exer | |
| Michael Mussallem, 48 Chairman,
CEO | $2.3M | $2.1M | Andre-Michel Ballester, 42 Pres,
VP, Europe and Intercontinental | -- | -- | Stuart Foster, 50 VP,
Global Operations | 935K | 2.1M | Bruce Bentcover, 46 VP,
CFO | 647K | -- | Bruce Garren, 54 VP,
Gen. Counsel, Sec. | -- | -- | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|